Eli Lilly and Company - 10 year dividend growth rate
Dividend history for stock LLY (Eli Lilly and Company) including dividend growth rate predictions based on history.
Year | Dividend | Estimated Yield on Cost |
---|---|---|
2034 | 12.867USD * | 1.73% |
2033 | 11.940USD * | 1.61% |
2032 | 11.079USD * | 1.49% |
2031 | 10.280USD * | 1.39% |
2030 | 9.539USD * | 1.29% |
2029 | 8.852USD * | 1.19% |
2028 | 8.213USD * | 1.11% |
2027 | 7.621USD * | 1.03% |
2026 | 7.072USD * | 0.95% |
2025 | 6.562USD * | 0.88% |
2024 | 6.089USD * | 0.82% |
2023 | 5.650USD | |
2022 | 3.920USD | |
2021 | 3.400USD | |
2020 | 2.960USD | |
2019 | 2.580USD | |
2018 | 2.250USD | |
2017 | 2.080USD | |
2016 | 2.040USD | |
2015 | 2USD | |
2014 | 1.960USD | |
2013 | 1.960USD | |
2012 | 1.960USD | |
2011 | 1.960USD | |
2010 | 1.960USD | |
2009 | 1.960USD | |
2008 | 1.880USD | |
2007 | 1.700USD | |
2006 | 1.600USD | |
2005 | 1.520USD | |
2004 | 1.420USD | |
2003 | 1.340USD | |
2002 | 1.240USD | |
2001 | 1.120USD | |
2000 | 1.040USD | |
1999 | 0.920USD | |
1998 | 0.800USD | |
1997 | 0.740USD | |
1996 | 0.684USD | |
1995 | 0.655USD | |
1994 | 0.625USD | |
1993 | 0.605USD | |
1992 | 0.550USD | |
1991 | 0.500USD | |
1990 | 0.410USD | |
1989 | 0.337USD | |
1988 | 0.288USD | |
1987 | 0.250USD | |
1986 | 0.225USD | |
1985 | 0.200USD | |
1984 | 0.186USD | |
1983 | 0.172USD | |
1982 | 0.163USD | |
1981 | 0.144USD | |
1980 | 0.138USD | |
1979 | 0.122USD | |
1978 | 0.103USD | |
1977 | 0.089USD | |
1976 | 0.078USD | |
1975 | 0.069USD | |
1974 | 0.061USD | |
1973 | 0.050USD | |
1972 | 0.023USD |
* These yearly dividends are calculated as current last years dividends times conservative dividend growth rate. Conservative dividend growth rate is calculated from DGR10 value and uses this function (in LLY case 7.77% was used as conservative DGR).
LLY
List: Contenders
Price: $741.74
Dividend Yield: 0.01%
Forward Dividend Yield: 0.71%
Payout Ratio: 93.69%
Dividend Per Share: 5.20 USD
Earnings Per Share: 5.79 USD
P/E Ratio: 133.87
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 2.6 million
Ebitda: 758.9 millionMarket Capitalization: 714.6 billion
Average Dividend Frequency: 4
Years Paying Dividends: 53
DGR3: 15.02%
DGR5: 13.93%
DGR10: 7.77%
DGR20: 6.15%